Mucolipidosis II (I Cell Disorder) Market Size & Forecasts 2026-2035, By Segments (End-User, Treatment, Symptoms), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Sanofi, Biomarin Pharmaceutical, Genzyme, Takeda, Kyowa Kirin)